SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,450.00    0.00 (0.00%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Update

18 Nov 2024 07:00

RNS Number : 5845M
Judges Scientific PLC
18 November 2024
Β 

Press Release

18 November 2024

Β 

Judges Scientific plc

Β 

("Judges Scientific" or the "Company")

Β 

Trading Update

Β 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, today provides an update on trading.

Β 

As announced at the time of the Group's Interim Results in September, several of our Group businesses had experienced a challenging first half, driven by difficult market conditions and the deferral of some projects into H2 or 2025. We expected the second half to show significant improvement, with a number of agreements signed too late to impact the first half but contributing to the second, in addition to the signature of a 2025 coring contract.

Β 

As anticipated, H2 will show progress compared to H1. However, achievement of the expectations for the full year, which were revised downwards in July, was reliant upon the crystallisation and delivery of certain orders. We now believe these will not all occur in time to deliver against the expectations before the end of the year.

Β 

Organic order intake YTD to the end of October has progressed 4.2% vs 2023 including a coring contract by Geotek. Order intake would be 1.6% down if we excluded this contract, indicating that the general level of orders across the Group has not yet recovered to the growth path traditional for our Group.

Β 

As a result, the Board now expects Adjusted basic earnings per share for the year to 31 December 2024 to be between 270p and 300p.

Β 

In spite of the disappointing trading performance, the Board is confident that the long-term growth drivers of our business remain solid.

Β 

Β 

For further information please contact:Β 

Β 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0)Β 20 3829 6970

Β 

Β 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

Β 

Panmure Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

TelΒ : +44 (0) 20 3100 2222

Β 

Β 

Investec Bank plcΒ (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000

Alma (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

Β 

Notes to editors:

Judges Scientific plcΒ (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarilyΒ UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. TheΒ UKΒ is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges ScientificΒ maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visitΒ www.judges.uk.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFFIILRLDLIS
Date   Source Headline
16th Nov 201510:58 amRNSBlocklisting Interim Review
6th Nov 20154:57 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:00 amRNSTotal Voting Rights
21st Oct 201512:00 pmRNSNew option schemes, Director/PDMR Shareholding
16th Oct 20153:24 pmRNSDirector/PDMR Shareholding
8th Oct 20155:08 pmRNSDirector/PDMR Shareholding
7th Oct 20152:10 pmRNSDirector/PDMR Shareholding
1st Oct 20157:00 amRNSTotal Voting Rights
28th Sep 20156:00 pmRNSDirector/PDMR Shareholding
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20155:29 pmRNSDirector/PDMR Shareholding
1st Sep 20157:03 amRNSTotal Voting Rights
7th Aug 20157:00 amRNSDirector/PDMR Shareholding
24th Jul 20155:21 pmRNSDirector/PDMR Shareholding and Notice of Results
23rd Jul 20157:00 amRNSTrading Statement
8th Jul 20155:24 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSTotal Voting Rights
8th Jun 20153:00 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSTotal Voting Rights
27th May 20152:18 pmRNSResult of AGM
22nd May 20157:00 amRNSPAYMENT OF DEFERRED CONSIDERATION
13th May 20152:17 pmRNSBlocklisting Application
6th May 20153:35 pmRNSDirector/PDMR Shareholding
29th Apr 201510:40 amRNSExercise of Options
21st Apr 201511:15 amRNSExercise of Options
16th Apr 20151:46 pmRNSIssue of Equity
9th Apr 20154:22 pmRNSDirector/PDMR Shareholding
8th Apr 20155:02 pmRNSDirector/PDMR Shareholding
31st Mar 20155:49 pmRNSDirector/PDMR Shareholding
31st Mar 20157:00 amRNSDirector/PDMR Shareholding
27th Mar 20157:00 amRNSFinal Results
11th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 201512:10 pmRNSNotice of Results
3rd Mar 20157:00 amRNSAppointment of Director and Board transition
10th Feb 20154:26 pmRNSExercise of Options
9th Feb 20155:06 pmRNSDirector/PDMR Shareholding
4th Feb 20155:56 pmRNSHolding(s) in Company
4th Feb 201511:26 amRNSHolding(s) in Company
23rd Jan 201511:45 amRNSDirector/PDMR Shareholding and Exercise of Options
22nd Jan 20154:26 pmRNSDirector/PDMR Shareholding
22nd Jan 20157:00 amRNSAcquisition
20th Jan 20157:00 amRNSTrading Statement
7th Jan 201511:29 amRNSDirector/PDMR Shareholding
23rd Dec 20142:10 pmRNSNew Term Loan and Acquisition Facility
11th Nov 20143:31 pmRNSDirector/PDMR Shareholding
16th Oct 20149:42 amRNSReplacement: Director/PDMR Shareholding
8th Oct 20142:31 pmRNSDirector/PDMR Shareholding
2nd Oct 20141:53 pmRNSIssue of Equity
29th Sep 20142:49 pmRNSHolding(s) in Company
24th Sep 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.